Skip to main content
Right Decisions for Health and Care
Right Decisions for Health and Care
Search for toolkits, guidelines and other information:
Search 'Polypharmacy guidance: realistic prescribing'...
Menu
All resources
Organisations
Learning & support
How to deliver RDS tools
Feedback
Right Decisions
Polypharmacy guidance: realistic prescribing
Medicines
Back
By Medicine
Metformin, sulfonylureas, glitazones
Announcements and latest updates
test announcement
Print this page
Metformin, sulfonylureas, glitazones
Polypharmacy guidance: realistic prescribing
Scottish Government Effective Prescribing & Therapeutics Division
Chapter 6: Endocrine system
CAUTION: Risk of lactic acidosis. Avoid if eGFR < 30 ml/min. Stop when at risk of dehydration
CAUTION: Hypoglycaemia: Active metabolites can accumulate when renal function is impaired
Avoid in patients with heart failure
Back to the top